Aggressive prostate cancer prognosis


aggressive prostate cancer prognosis

The current situation of cancer morbidity and mortality in the light of the National Cancer Registry, Hungary. Studies on prostatic cancer. The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate.

aggressive prostate cancer prognosis

Aggressive prostate cancer prognosis Res. Treatment strategies for advanced prostate cancer. Actualities in the medical treatment of metastatic prostate cancer. Novelties in diagnostics and treatment of prostate cancer. Androgen-deprivation therapy alone or with aggressive prostate cancer prognosis in non-castrate metastatic prostate cancer GETUG-AFU 15 : a randomised, open-label, phase 3 trial.

Stories of Advanced Prostate Cancer Remissions - Ask a Prostate Cancer Expert, Mark Scholz, MD

Lancet Oncol. J Clin Oncol. Chemohormonal therapy in metastatic hormone-sensitive prostate cancer. N Engl J Med. Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer STAMPEDE : survival results from an adaptive, multiarm, multistage, platform randomised controlled trial. Lancet ; — Eur Urol.

Treatment Methods for Early and Advanced Prostate Cancer

Ann Oncol. Androgen receptor-mediated processes in castrate-resistant metastatic prostate cancer.

aggressive prostate cancer prognosis

Abiraterone and increased survival in metastatic prostate cancer. Abiraterone in metastatic prostate cancer without previous chemotherapy.

aggressive prostate cancer prognosis

Abiraterone plus prednisone in metastatic, castration-sensitive prostate cancer. Abiraterone for prostate cancer not previously treated with hormone therapy. Adding abiraterone or docetaxel to long-term hormone therapy for prostate cancer: directly randomised data from the STAMPEDE multi-arm, multi-stage platform protocol.

aggressive prostate cancer prognosis

The evolving landscape of metastatic hormone-sensitive prostate cancer: a critical review of the evidence for adding docetaxel or abiraterone to androgen deprivation. Prostate Cancer Prostatic Dis.

aggressive prostate cancer prognosis